| 臺大學術典藏 |
2022-05-05T03:09:19Z |
Genetic association analysis of cell cycle regulators reveals YWHAZ has prognostic significance in prostate cancer
|
Yu C.-C.; Chen L.-C.; Lin W.-H.; Lin V.C.; CHAO YUAN HUANG; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2022-03-24T03:27:23Z |
A modified Nordic prediction model of road traffic noise in a Taiwanese city with significant motorcycle traffic
|
Chang T.-Y.; Lin H.-C.; Yang W.-T.; Bao B.-Y.; CHANG-CHUAN CHAN |
| 臺大學術典藏 |
2021-10-14T02:46:03Z |
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy
|
Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; CHAO-YUAN HUANG; Pu Y.-S.; Yu C.-C.; Huang C.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:02Z |
Prognostic significance of genetic polymorphisms on prostate-specific antigen recurrence after a radical prostatectomy
|
Tsai Y.-F.; Bao B.-Y.; Liu C.-C.; Huang C.-N.; Yu C.-C.; Wu T.T.; CHAO-YUAN HUANG; Pu Y.-S.; Chang C.-F.; Huang C.-H.; Wu W.-J.; Huang S.-P. |
| 臺大學術典藏 |
2021-10-14T02:46:01Z |
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
|
Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Liu C.-C.; CHAO-YUAN HUANG; Pu Y.-S.; Yu C.-C.; Wu T.T.; Huang C.-N.; Huang C.-H.; Wu W.-J. |
| 臺大學術典藏 |
2021-10-14T02:46:00Z |
Genetic variants in CASP3, BMP5, and IRS2 genes may influence survival in prostate cancer patients receiving androgen-deprivation therapy
|
Huang S.-P.; Bao B.-Y.; Hour T.-C.; CHAO-YUAN HUANG; Yu C.-C.; Liu C.-C.; Lee Y.-C.; Huang C.-N.; Pao J.-B.; Huang C.-H. |
| 臺大學術典藏 |
2021-10-14T02:46:00Z |
Genetic polymorphisms in oestrogen receptor-binding sites affect clinical outcomes in patients with prostate cancer receiving androgen-deprivation therapy
|
Huang C.-N.; Huang S.-P.; Pao J.-B.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; CHAO-YUAN HUANG; Hsieh C.-J.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:58Z |
Prognostic significance of cyclin d1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy
|
Yu C.-C.; Lin V.C.; CHAO-YUAN HUANG; Liu C.-C.; Wang J.-S.; Wu T.T.; Pu Y.-S.; Huang C.-H.; Huang C.-N.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:57Z |
Vitamin D receptor gene variants and clinical outcomes after androgen-deprivation therapy for prostate cancer
|
Pao J.-B.; Yang Y.-P.; Huang C.-N.; Huang S.-P.; Hour T.-C.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; CHAO-YUAN HUANG; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:57Z |
Molecular markers in key steroidogenic pathways, circulating steroid levels, and prostate cancer progression
|
L?vesque E.; Huang S.-P.; Audet-Walsh E.; Lacombe L.; Bao B.-Y.; Fradet Y.; Laverdi?re I.; Rouleau M.; CHAO-YUAN HUANG; Yu C.-C.; Caron P.; Guillemette C. |
| 臺大學術典藏 |
2021-10-14T02:45:57Z |
Molecular Markers in Sex Hormone Pathway Genes Associated with the Efficacy of Androgen-Deprivation Therapy for Prostate Cancer
|
Yu C.-C.; Huang S.-P.; Lee Y.-C.; CHAO-YUAN HUANG; Liu C.-C.; Hour T.-C.; Huang C.-N.; You B.-J.; Chang T.-Y.; Huang C.-H.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:56Z |
Common variants in IGF1 pathway genes and clinical outcomes after radical prostatectomy
|
Chang C.-F.; Pao J.-B.; Yu C.-C.; CHAO-YUAN HUANG; Huang S.-P.; Yang Y.-P.; Huang C.-N.; Chang T.-Y.; You B.-J.; Lee H.-Z.; Hour T.-C.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:55Z |
Genetic variations in TP53 binding sites are predictors of clinical outcomes in prostate cancer patients
|
Lin V.C.; CHAO-YUAN HUANG; Lee Y.-C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:55Z |
Genetic variants in nuclear factor-kappa B binding sites are associated with clinical outcomes in prostate cancer patients
|
Huang S.-P.; Lin V.C.; Lee Y.-C.; Yu C.-C.; CHAO-YUAN HUANG; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:51Z |
Genetic variants in the Hippo pathway predict biochemical recurrence after radical prostatectomy for localized prostate cancer
|
CHAO-YUAN HUANG; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Juang S.-H.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:51Z |
Genetic variants in microRNAs and microRNA target sites predict biochemical recurrence after radical prostatectomy in localized prostate cancer
|
Huang S.-P.; Levesque E.; Guillemette C.; Yu C.-C.; CHAO-YUAN HUANG; Lin V.C.; Chung I.-C.; Chen L.-C.; Laverdi?re I.; Lacombe L.; Fradet Y.; Chang T.-Y.; Lee H.-Z.; Juang S.-H.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:49Z |
Genetic interaction analysis of TCF7L2 for biochemical recurrence after radical prostatectomy in localized prostate cancer
|
Chen C.-S.; CHAO-YUAN HUANG; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:48Z |
Prognostic significance of genetic polymorphisms in disease progression and survival in prostate cancer after androgen deprivation therapy
|
Huang T.-Y.; Chien T.-M.; Liu C.-C.; Lee H.-Y.; Yu C.-C.; CHAO-YUAN HUANG; Chang C.-F.; Huang C.-H.; Wu W.-J.; Bao B.-Y.; Huang S.-P. |
| 臺大學術典藏 |
2021-10-14T02:45:46Z |
Genetic variants of the autophagy pathway as prognostic indicators for prostate cancer
|
CHAO-YUAN HUANG; Huang S.-P.; Lin V.C.; Yu C.-C.; Chang T.-Y.; Lu T.-L.; Chiang H.-C.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:42Z |
Genetic variants in ultraconserved regions associate with prostate cancer recurrence and survival
|
Bao B.-Y.; Lin V.C.; Yu C.-C.; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Lee H.-Z.; Pao J.-B.; CHAO-YUAN HUANG; Huang S.-P. |
| 臺大學術典藏 |
2021-10-14T02:45:40Z |
Prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy
|
Lee C.-H.; Pao J.-B.; Lu T.-L.; Lee H.-Z.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG; Lin V.C.; Yu C.-C.; Yin H.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:39Z |
Prognostic relevance of methylenetetrahydrofolate reductase polymorphisms for prostate cancer
|
Lin V.C.; Lu T.-L.; Yin H.-L.; Yang S.-F.; Lee Y.-C.; Liu C.-C.; CHAO-YUAN HUANG; Yu C.-C.; Chang T.-Y.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:39Z |
Inherited variants in Wnt pathway genes influence outcomes of prostate cancer patients receiving androgen deprivation therapy
|
Geng J.-H.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:38Z |
Vitamin D receptor-binding site variants affect prostate cancer progression
|
Lin V.C.; Huang S.-P.; Ting H.-J.; Ma W.-L.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:35Z |
Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer
|
Lin V.C.; Huang S.-P.; CHAO-YUAN HUANG; Yu C.-C.; Yin H.-L.; Huang T.-Y.; Lee C.-H.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:30Z |
A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer
|
Huang E.Y.; Chang Y.-J.; Huang S.-P.; Lin V.C.; Yu C.-C.; CHAO-YUAN HUANG; Yin H.-L.; Chang T.-Y.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:28Z |
Clinical significance of glutamate metabotropic receptors in renal cell carcinoma risk and survival
|
CHAO-YUAN HUANG; Hsueh Y.-M.; Chen L.-C.; Cheng W.-C.; Yu C.-C.; Chen W.-J.; Lu T.-L.; Lan K.-J.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:27Z |
Genetic variants in the circadian rhythm pathway as indicators of prostate cancer progression
|
Yu C.-C.; Chen L.-C.; Chiou C.-Y.; Chang Y.-J.; Lin V.C.; CHAO-YUAN HUANG; Lin I.-L.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:26Z |
Effect of genetic variants in cell adhesion pathways on the biochemical recurrence in prostate cancer patients with radical prostatectomy
|
Yu C.-C.; Chen L.-C.; Lin V.C.; CHAO-YUAN HUANG; Cheng W.-C.; Hsieh A.-R.; Chang T.-Y.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:25Z |
Prognostic value of CD1B in localised prostate cancer
|
Lee C.-H.; Chen L.-C.; Yu C.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:24Z |
Genetic association analysis identifies a role for ANO5 in prostate cancer progression
|
Yu C.-C.; Chen L.-C.; CHAO-YUAN HUANG; Lin V.C.; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:23Z |
Genetic analysis reveals a significant contribution of ces1 to prostate cancer progression in taiwanese men
|
Ke C.-C.; Chen L.-C.; Yu C.-C.; Cheng W.-C.; CHAO-YUAN HUANG; Lin V.C.; Lu T.-L.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Genetic analysis identifies the role of HLF in renal cell carcinoma
|
CHAO-YUAN HUANG; HUANG S.-P.; HSUEH Y.-M.; CHEN L.-C.; LU T.-L.; BAO B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:22Z |
Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma
|
Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; Pu Y.-S.; CHAO-YUAN HUANG; Hsueh Y.-M. |
| 臺大學術典藏 |
2021-10-14T02:45:19Z |
NRG1 genetic variant influences the efficacy of androgen-deprivation therapy in men with prostate cancer
|
Huang S.-P.; Chen Y.-T.; Chen L.-C.; Lee C.-H.; CHAO-YUAN HUANG; Yu C.-C.; Lin V.C.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-10-14T02:45:17Z |
Genetic variants in MAPK10 modify renal cell carcinoma susceptibility and clinical outcomes
|
Tsai Y.-C.; CHAO-YUAN HUANG; Hsueh Y.-M.; Fan Y.-C.; Fong Y.-C.; Huang S.-P.; Geng J.-H.; Chen L.-C.; Lu T.-L.; Bao B.-Y. |
| 臺大學術典藏 |
2021-05-18T08:20:14Z |
Genetic association analysis of cell cycle regulators reveals YWHAZ has prognostic significance in prostate cancer
|
Yu C.-C.; Chen L.-C.; Lin W.-H.; Lin V.C.; CHAO-YUAN HUANG; Lu T.-L.; Lee C.-H.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:41Z |
Polymorphisms inside MicroRNAs and MicroRNA target sites predict clinical outcomes in prostate cancer patients receiving androgen-deprivation therapy
|
Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Chen L.-M.; Hsieh C.-J.; Huang S.-P. |
| 臺大學術典藏 |
2021-02-02T00:46:40Z |
Impact of prostate-specific antigen (PSA) nadir and time to PSA nadir on disease progression in prostate cancer treated with androgen-deprivation therapy
|
Huang S.-P. ;Bao B.-Y. ;Wu M.-T. ;Choueiri T.K. ;Goggins W.B. ;Huang C.-Y. ;Yeong-Shiau Pu ;Yu C.-C. ;Huang C.-H.; Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Huang C.-Y.; YEONG-SHIAU PU; Yu C.-C.; Huang C.-H. |
| 臺大學術典藏 |
2021-02-02T00:46:38Z |
Prognostic significance of genetic polymorphisms on prostate-specific antigen recurrence after a radical prostatectomy
|
Tsai Y.-F.; Bao B.-Y.; Liu C.-C.; Huang C.-N.; Yu C.-C.; Wu T.T.; Huang C.-Y.; YEONG-SHIAU PU; Chang C.-F.; Huang C.-H.; Wu W.-J.; Huang S.-P. |
| 臺大學術典藏 |
2021-02-02T00:46:37Z |
Genetic polymorphisms in androgen receptor-binding sites predict survival in prostate cancer patients receiving androgen-deprivation therapy
|
Huang C.-N.; Huang S.-P.; Pao J.-B.; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Juang S.-H.; Wu P.-P.; YEONG-SHIAU PU; Hsieh C.-J.; Bao B.-Y. |
| 臺大學術典藏 |
2021-02-02T00:46:37Z |
Significant associations of prostate cancer susceptibility variants with survival in patients treated with androgen-deprivation therapy
|
Bao B.-Y.; Pao J.-B.; Huang C.-N.; YEONG-SHIAU PU; Chang T.-Y.; Lan Y.-H.; Lu T.-L.; Lee H.-Z.; Chen L.-M.; Ting W.-C.; Hsieh C.-J.; Huang S.-P. |
| 臺大學術典藏 |
2021-02-02T00:46:37Z |
Significant associations of prostate-specific antigen nadir and time to prostate-specific antigen nadir with survival in prostate cancer patients treated with androgen-deprivation therapy
|
Huang S.-P.; Bao B.-Y.; Wu M.-T.; Choueiri T.K.; Goggins W.B.; Liu C.-C.; Huang C.-Y.; YEONG-SHIAU PU; Yu C.-C.; Wu T.T.; Huang C.-N.; Huang C.-H.; Wu W.-J. |
| 臺大學術典藏 |
2021-02-02T00:46:33Z |
Prognostic significance of cyclin d1 polymorphisms on prostate-specific antigen recurrence after radical prostatectomy
|
Yu C.-C.; Lin V.C.; Huang C.-Y.; Liu C.-C.; Wang J.-S.; Wu T.T.; YEONG-SHIAU PU; Huang C.-H.; Huang C.-N.; Huang S.-P.; Bao B.-Y. |
| 臺大學術典藏 |
2021-02-02T00:45:57Z |
Polymorphism of nucleotide binding domain-like receptor protein 3 (NLRP3) increases susceptibility of total urinary arsenic to renal cell carcinoma
|
Chung C.-J.;Bao B.-Y.;Lin Y.-C.;Huang Y.-L.;Shiue H.-S.;Ao P.-L.;Yeong-Shiau Pu;Huang C.-Y.;Hsueh Y.-M.; Chung C.-J.; Bao B.-Y.; Lin Y.-C.; Huang Y.-L.; Shiue H.-S.; Ao P.-L.; YEONG-SHIAU PU; Huang C.-Y.; Hsueh Y.-M. |
| 臺大學術典藏 |
2018-09-10T18:07:38Z |
A common regulatory variant in SLC35B4 influences the recurrence and survival of prostate cancer
|
Huang, E.Y.;Chang, Y.-J.;Huang, S.-P.;Lin, V.C.;Yu, C.-C.;Huang, C.-Y.;Yin, H.-L.;Chang, T.-Y.;Lu, T.-L.;Bao, B.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T18:03:33Z |
Cancer stem cell gene variants predict disease recurrence in patients treated with radical prostatectomy for prostate cancer
|
Lin, V.C.;Huang, S.-P.;Huang, C.-Y.;Yu, C.-C.;Yin, H.-L.;Huang, T.-Y.;Lee, C.-H.;Lu, T.-L.;Bao, B.-Y.; CHAO-YUAN HUANG |
| 臺大學術典藏 |
2018-09-10T15:35:00Z |
Inherited variants in Wnt pathway genes influence outcomes of prostate cancer patients receiving androgen deprivation therapy
|
Geng, J.-H.;Lin, V.C.;Yu, C.-C.;Huang, C.-Y.;Yin, H.-L.;Chang, T.-Y.;Lu, T.-L.;Huang, S.-P.;Bao, B.-Y.; CHAO-YUAN HUANG; Geng, Jiun-Hung; Liu, Yuan-Hung; Lin, Victor C.; Peng, Kai-Yen; Yu, Chia-Cheng; Chiu, Yu-Wei; Ho, Yi-Lwun; Huang, Chao-Yuan; Yin, Hsin-Ling; Wang, Yao-Horng; Shun, Chia-Tung; Chang, Ta-Yuan; Lu, Te-Ling; Huang, Shih-Yun; Lin, Yi-Shuan; Huang, Shu-Pin; de Vries, Antoine A. F.; Bao, Bo-Ying; Pijnappels, Daniel A.; Lee, Nan-Ting; Yen, B. Linju; Yen, Men-Luh; 嚴孟祿; 孫家棟; 何奕倫 |
| 臺大學術典藏 |
2018-09-10T15:35:00Z |
Prognostic relevance of methylenetetrahydrofolate reductase polymorphisms for prostate cancer
|
Lin, V.C.;Lu, T.-L.;Yin, H.-L.;Yang, S.-F.;Lee, Y.-C.;Liu, C.-C.;Huang, C.-Y.;Yu, C.-C.;Chang, T.-Y.;Huang, S.-P.;Bao, B.-Y.; CHAO-YUAN HUANG; Lin, Victor C.; Lu, Te-Ling; Yin, Hsin-Ling; Chen, Poda; Yang, Sheau-Fang; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chao-Yuan; Yu, Chia-Cheng; Chang, Ta-Yuan; Huang, Shu-Pin; Bao, Bo-Ying |
| 臺大學術典藏 |
2018-09-10T15:34:15Z |
Prognostic value of prostaglandin-endoperoxide synthase 2 polymorphisms in prostate cancer recurrence after radical prostatectomy
|
Lee, C.-H.;Pao, J.-B.;Lu, T.-L.;Lee, H.-Z.;Lee, Y.-C.;Liu, C.-C.;Huang, C.-Y.;Lin, V.C.;Yu, C.-C.;Yin, H.-L.;Huang, S.-P.;Bao, B.-Y.; Lee, Cheng-Hsueh; CHAO-YUAN HUANG; Pao, Jiunn-Bey; Lu, Te-Ling; Lee, Hong-Zin; Lee, Yung-Chin; Liu, Chia-Chu; Huang, Chao-Yuan; Lin, Victor C.; Yu, Chia-Cheng; Yin, Hsin-Ling; Huang, Shu-Pin; Bao, Bo-Ying |
